<bill session="108" type="h" number="608" updated="2023-01-15T21:48:59Z">
  <state datetime="2003-02-05">REFERRED</state>
  <status>
    <introduced datetime="2003-02-05"/>
  </status>
  <introduced datetime="2003-02-05"/>
  <titles>
    <title type="display">Pharmaceutical Products Price Equity Act</title>
    <title type="official" as="introduced">To provide for prices of pharmaceutical products that are fair to the producer and the consumer, and for other purposes.</title>
    <title type="short" as="introduced">Pharmaceutical Products Price Equity Act</title>
  </titles>
  <sponsor bioguide_id="O000159"/>
  <cosponsors/>
  <actions>
    <action datetime="2003-02-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-02-05" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-02-05">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-02-14">
      <text>Referred to the Subcommittee on Commerce, Trade and Consumer Protection.</text>
    </action>
    <action datetime="2003-03-06">
      <text>Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU03" name="House Judiciary" subcommittee="Courts, Intellectual Property, and the Internet" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF17" name="House Energy and Commerce" subcommittee="Innovation, Data, and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Civil actions and liability"/>
    <term name="Class actions (Civil procedure)"/>
    <term name="Commerce"/>
    <term name="Crime and Law Enforcement"/>
    <term name="Damages"/>
    <term name="Drug industry"/>
    <term name="Economics and Public Finance"/>
    <term name="Fines (Penalties)"/>
    <term name="Government Operations and Politics"/>
    <term name="Injunctions"/>
    <term name="Law"/>
    <term name="Legal fees"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Price regulation"/>
    <term name="Punitive damages"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in House">Pharmaceutical Products Price Equity Act - Directs the President to issue orders and regulations, and establish procedures and reporting requirements, to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions.</summary>
</bill>
